首页> 外文OA文献 >Optimizing Pharmacotherapy for Limiting Cardiovascular Remodeling A Matter of Timing Therapy to Match Biology**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

【2h】

Optimizing Pharmacotherapy for Limiting Cardiovascular Remodeling A Matter of Timing Therapy to Match Biology**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

机译：优化药物治疗以限制心血管重塑与生物学相匹配的时机疗法**《美国心脏病学会杂志》上发表的社论反映了作者的观点，不一定代表JACC或美国心脏病学会的观点。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jugdutt Bodh I.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions (Journal of the American College of Cardiology (2011) 58 (2550-2583) DOI:10.1016/j.jacc.2011.08. 008) [J] . HammerS., LevineG.M., BatesE.R., Journal of the American College of Cardiology . 2012,第11期

机译：2011年ACCF / AHA / SCAI经皮冠状动脉介入治疗指南：摘要：美国心脏病学会基金会/美国心脏协会实践指南工作组与心血管血管造影和干预学会的报告（《美国心脏病学会杂志（ 2011）58（2550-2583）DOI：10.1016 / j.jacc.2011.08.008）
2. Erratum: 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the american college of cardiology foundation/american heart association task force on practice guidelines (Journal of the American College of Cardiology (2012 60 (1297313) DOI: 10.1016/j.jacc. 2012.07.009) [J] . TracyC.M., EpsteinA.E., DarbarD. Journal of the American College of Cardiology . 2012,第24期

机译：勘误：2012年ACCF / AHA / HRS重点更新了2008年基于设备的心律异常治疗指南的更新：美国心脏病学会基金会/美国心脏协会特别工作组关于实践指南的报告（《美国心脏病学会杂志》（2012 60（1297313）DOI：10.1016 / j.jacc。2012.07.009）
3. Optimizing pharmacotherapy for limiting cardiovascular remodeling a matter of timing therapy to match biology. [J] . Jugdutt BI Journal of the American College of Cardiology . 2011,第20期

机译：优化药物疗法以限制心血管重塑的时机选择要与生物学相匹配。
4. Pharmacotherapy in Older Adults with Cardiovascular Disease: Report from an American College of Cardiology American Geriatrics Society and National Institute on Aging Workshop [O] . Janice B. Schwartz, Kenneth E. Schmader, Joseph T. Hanlon, -1

机译：老年心血管疾病的药物治疗：美国心脏病学会美国老年医学会和美国国立衰老研究所的报告
5. Inorganic Nitrate Therapy Improves Doxorubicin-Induced Cardiomyopathy A New Window for an Affordable Cardiovascular Therapy for Everyone?⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. [O] . Daiber Andreas, Gori Tommaso, Münzel Thomas 2011

机译：无机硝酸盐疗法可改善阿霉素诱导的心肌病，是所有人都能负担得起的心血管疗法的新窗口？⁎⁎《美国心脏病学会杂志》上发表的社论反映了作者的观点，并不一定代表JACC或美国人的观点心脏病学院。

著录项

引文网络

相似文献

相关主题

期刊订阅